Atlas Trials

Indolent Non-Hodgkin's Lymphomas

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Indolent Non-Hodgkin's Lymphomas

RecordFirmDate
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas (NCT01732913)Gilead Sciences2013-01-16
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas (NCT01732926)Gilead Sciences2013-01-02

Track Indolent Non-Hodgkin's Lymphomas automatically

Every clearance here is in the API, with alerts when new ones post.